Thursday, November 21, 2024

Pulse

Giiant Pharma Secures Another PALI-2108 Milestone Payout

Could the pathway to a new treatment for moderate-to-severe ulcerative colitis be unfolding before our eyes? This is a question on the minds of...

MicroStrategy’s Bitcoin Bet: A Whale’s Game Changer?

Have you ever considered what fuels the economic engines of technology companies like MicroStrategy Incorporated? It's a multifaceted story of strategic investments, bold leadership,...

Enveric Biosciences Picks EB-003 as Top Mental Health Drug

Could the tide be turning in the pursuit of treating mental health disorders? On a rather hopeful note, Enveric Biosciences, a biotechnology firm, made...

European Equities Dip on Year-End Activity Amid Muted Trading

As the year draws to a close, investors across Europe adjusted their portfolios, leading to a slight downturn in stock markets on the continent....

SPY ETF Nears $500B Mark Amid Record S&P 500 Surge and 2023 Inflows

Could a single financial instrument embody the optimism of a year in the stock market? The SPDR S&P 500 ETF Trust (SPY), as it...

DoD Boosts MediWound’s NexoBrid with Fresh Grant Support

What does it mean when a biopharmaceutical company receives a substantial grant from the Department of Defense for burn care technology? For MediWound Ltd,...

DatChat Unveils AI-Powered Social Gaming and Dev Platform, Stock Soars

Have you heard the latest buzz in the realm of artificial intelligence and social gaming? DatChat, a company that may have flown under your...

Hashdex Debuts Ad Blitz Amid Bitcoin ETF Anticipation

Could a new chapter in the history of financial innovation be upon us? As we delve into the intriguing developments within the cryptocurrency sphere,...